We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

J&J Units Resolve Spat Over Razadyne-ER Patent

Law360 (March 30, 2009, 12:00 AM EDT) -- Three Johnson & Johnson units have resolved a dispute with a trio of generic-drug makers that they accused of infringing a patent covering the Alzheimer’s treatment Razadyne-ER.

According to stipulated dismissals...
To view the full article, register now.